查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963947

子宫内膜消融术市场－全球产业规模、份额、趋势、机会、预测：按产品、最终用途、地区和竞争对手划分，2021-2031年

Endometrial Ablation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球子宫内膜消融市场预计将从 2025 年的 20.9 亿美元成长到 2031 年的 28.7 亿美元，年复合成长率为 5.43%。

作为一种微创手术，子宫内膜切除术已成为月经过多女性避免大型手术的重要治疗方法。这一市场成长的主要驱动因素是医疗服务提供者和患者越来越倾向于保留子宫的治疗方案（预计可缩短住院时间和恢復时间），以及全球范围内异常子宫出血发病率的上升。事实上，美国血液学会指出，2024年约有五分之一的女性受到月经，这显着提升了对有效治疗方法的需求。

市场概览
预测期 2027-2031
市场规模：2025年 20.9亿美元
市场规模：2031年 28.7亿美元
复合年增长率：2026-2031年 5.43%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

然而，这些手术的长期疗效和术后併发症风险在市场中面临重大挑战。阻碍其广泛应用的主要障碍是治疗失败的可能性，这往往会导致后续需要子宫切除术。因此，医生在比较消融术的永久性与根治性手术方案时可能会犹豫不决。

市场驱动因素

全球子宫内膜消融术市场的主要驱动因素是异常子宫出血（AUB）和月经过多的盛行率不断上升，尤其是在育龄女性族群老化的情况下。随着女性接近闭经，月经的发生率增加，寻求有效且保留子宫治疗的患者群体也不断扩大。这直接导致手术数量的增加，因为患者倾向于选择创伤较小的治疗方案而非大型手术。发表于2025年3月《澳洲医学杂誌》的一项研究也印证了这种日益加重的临床负担。研究发现，月经过多的盛行率随年龄显着增加，48岁女性的盛行率高达32.1%，凸显了寻找可靠的子宫切除术替代方案的迫切需求。

同时，第二代消融设备的科技进步，特别是高频和微创系统，正在改变市场格局。这些创新提高了安全性，缩短了恢復时间，加速了其在门诊环境中的应用。领先的製造商报告称，这些产品线带来了持续的财务成长。例如，2025年2月，Hologic宣布其妇科手术部门的收入达到1.663亿美元（成长2.5%），这主要得益于微创解决方案的推动。同样，2025年5月，Olympus Corporation宣布其治疗解决方案部门的收入成长了6.9%，证实了其先进妇科技术的商业性成功不断扩大。

市场挑战

全球子宫内膜消融术市场的成长受到长期治疗失败风险的显着限制。这种风险通常需要二次手术干预，儘管该手术属于微创手术，但子宫内膜再生的可能性仍可能导致月经復发。这使得临床医生和患者对子宫切除术犹豫不决，他们认为子宫切除术是更可靠的永久性解决方案。因此，人们更倾向于选择一次根治性手术而非效果不稳定的技术，这限制了消融设备的普及。

此外，再次治疗带来的临床和经济负担会对市场潜力产生负面影响。如果患者需要再次手术，那么最初的益处，例如缩短恢復时间和住院时间，实际上将被抵消。欧洲妇科内视镜学会2024年的一项纵向分析也支持了这个问题，该分析显示，约16.5%的女性在首次子宫内膜消融术后五年内接受了子宫切除术，这凸显了再次手术带来的重大挑战，限制了市场的发展。

市场趋势

重塑产业的一个关键趋势是，手术环境正加速向门诊和诊所转移，这主要是由于医疗机构对经济高效的工作流程的需求日益增长，以减轻其后勤负担。一次性预组装便利套装的开发正积极推动这一转变，这些套装简化了各个部件的采购和消毒流程，使其更易于在非医院环境中实施。例如，Minerva Surgical 于 2025 年 5 月宣布推出 HERizon™ Hysto-Kit，这是一款全面的单次使用套装，旨在缩短门诊子宫镜检查的时间，并确保操作流程的一致性。这直接满足了在传统手术室之外提供高效医疗服务日益增长的需求。

同时，作为热消融疗法的替代方案，冷冻消融疗法正逐渐兴起，其重点在于提高患者舒适度并减少术中麻醉用量。与依赖热能的射频消融系统不同，冷冻疗法利用极低的温度破坏子宫内膜，并具有天然的镇痛效果，因此特别适合在诊所进行清醒状态下的手术。为了支持这项技术的日益普及，ChannelMed Systems公司于2025年11月宣布，其Selene®冷冻治疗设备已成功完成超过5,000例手术。这表明，这种治疗月经过多的新方法正被越来越多的临床医生所接受。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球子宫内膜消融市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品特定方法（冷冻消融、射频消融术、水热消融、热感球消融、微波能等）
    • 依用途（医院/诊所、门诊手术中心、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美子宫内膜消融术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲子宫内膜消融术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区子宫内膜消融术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲子宫内膜消融术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲子宫内膜消融术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球子宫内膜消融市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Boston Scientific
  • Hologic
  • Minerva Surgical
  • CooperSurgical
  • Medtronic
  • Olympus
  • Karl Storz
  • Ethicon
  • Stryker
  • Johnson & Johnson

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21148

The Global Endometrial Ablation Market is projected to expand from USD 2.09 Billion in 2025 to USD 2.87 Billion by 2031, growing at a CAGR of 5.43%. As a minimally invasive surgical procedure utilized to destroy the uterine endometrial lining, it serves as a key treatment for women with menorrhagia who prefer to avoid major surgery. This market growth is primarily fueled by a growing preference among both healthcare providers and patients for uterus-sparing methods that reduce hospital stays and recovery times, alongside a rising global incidence of abnormal uterine bleeding; indeed, the American Society of Hematology noted in 2024 that heavy menstrual bleeding affects roughly one in five females, driving substantial demand for effective interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.09 Billion
Market Size 2031USD 2.87 Billion
CAGR 2026-20315.43%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

However, the market faces significant challenges regarding the long-term efficacy of these procedures and the risk of post-operative complications. A major barrier to wider adoption is the potential for treatment failure, which often leads to the need for subsequent hysterectomies, causing clinicians to hesitate when comparing the permanence of ablation against definitive surgical alternatives.

Market Driver

The primary driver of the global endometrial ablation market is the rising prevalence of abnormal uterine bleeding (AUB) and menorrhagia, especially within the aging reproductive demographic. As women near perimenopause, menstrual irregularities become more frequent, creating a large patient population seeking effective, uterus-sparing treatments, which directly translates into higher procedural volumes as patients choose less invasive options over major surgeries. This increasing clinical burden is highlighted by a study in the Medical Journal of Australia from March 2025, which found that the prevalence of heavy menstrual bleeding rises significantly with age, affecting 32.1% of women at 48 years, thereby reinforcing the urgent need for reliable non-hysterectomy solutions.

Simultaneously, the market is being transformed by technological advancements in second-generation ablation devices, particularly radiofrequency and minimally invasive systems. These innovations provide better safety profiles and shorter recovery times, promoting their adoption in outpatient settings, while leading manufacturers report sustained financial growth linked to these portfolios. For instance, Hologic, Inc. reported in February 2025 that its GYN Surgical division achieved $166.3 million in revenue, a 2.5% increase driven by minimally invasive solutions, and Olympus Corporation announced in May 2025 that its Therapeutic Solutions Division saw a 6.9% revenue rise, confirming the expanding commercial success of advanced gynecological technologies.

Market Challenge

The growth of the Global Endometrial Ablation Market is significantly hindered by the risk of long-term treatment failure, which often necessitates secondary surgical interventions. Although the procedure is valued for being minimally invasive, the potential for endometrial regrowth can lead to the recurrence of heavy menstrual bleeding, causing hesitation among clinicians and patients who may view hysterectomy as a more reliable solution for permanent relief. Consequently, the preference for a one-time curative surgery over a technique with variable durability limits the widespread adoption of ablation devices.

Furthermore, the clinical and economic burden of repeat procedures negatively impacts market potential, as the initial benefits of reduced recovery time and hospital stays are effectively negated when patients require subsequent surgeries. This issue is substantiated by a 2024 longitudinal analysis from the European Society for Gynaecological Endoscopy, which indicated that approximately 16.5% of women underwent a hysterectomy within five years of their initial endometrial ablation, highlighting the significant challenge of re-intervention that restricts the market's trajectory.

Market Trends

A major trend reshaping the industry is the accelerated transition toward ambulatory and office-based surgical settings, driven by the demand for cost-effective, streamlined workflows that reduce logistical burdens on healthcare providers. This shift is actively supported by the development of single-use, pre-assembled convenience kits that remove the complexity of sourcing and sterilizing individual components, thereby facilitating easier adoption in non-hospital environments. Illustrating this operational evolution, Minerva Surgical announced in May 2025 the launch of the HERizon(TM) Hysto-Kit, a comprehensive single-use package designed to save time and ensure procedural consistency for clinicians performing hysteroscopy in outpatient settings, directly addressing the growing demand for efficient care outside the traditional operating room.

In parallel, the market is witnessing the rise of cryoablation solutions as a distinct alternative to heat-based modalities, focusing on enhanced patient comfort and reduced intra-operative anesthesia requirements. Unlike radiofrequency systems that rely on thermal energy, cryotherapy uses extreme cold to destroy the endometrial lining, offering a natural analgesic effect that makes it particularly suitable for awake procedures in office environments. Validating the rising adoption of this technology, Channel Medsystems announced in November 2025 that it had surpassed 5,000 procedures with its Cerene(R) Cryotherapy device, underscoring the expanding clinical acceptance of this novel approach for managing heavy menstrual bleeding.

Key Market Players

  • Boston Scientific
  • Hologic
  • Minerva Surgical
  • CooperSurgical
  • Medtronic
  • Olympus
  • Karl Storz
  • Ethicon
  • Stryker
  • Johnson & Johnson

Report Scope

In this report, the Global Endometrial Ablation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endometrial Ablation Market, By Product

  • Cryoablation
  • Radiofrequency Ablation
  • Hydrothermal Ablation
  • Thermal Balloon
  • Microwave Energy
  • Others

Endometrial Ablation Market, By End Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Endometrial Ablation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Endometrial Ablation Market.

Available Customizations:

Global Endometrial Ablation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endometrial Ablation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy, Others)
    • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Endometrial Ablation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Endometrial Ablation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Endometrial Ablation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Endometrial Ablation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Endometrial Ablation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Endometrial Ablation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Endometrial Ablation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Endometrial Ablation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Endometrial Ablation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Endometrial Ablation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Endometrial Ablation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Endometrial Ablation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Endometrial Ablation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Endometrial Ablation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Endometrial Ablation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Endometrial Ablation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Endometrial Ablation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Endometrial Ablation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Endometrial Ablation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Endometrial Ablation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. South America Endometrial Ablation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Endometrial Ablation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Endometrial Ablation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Endometrial Ablation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Endometrial Ablation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hologic
  • 15.3. Minerva Surgical
  • 15.4. CooperSurgical
  • 15.5. Medtronic
  • 15.6. Olympus
  • 15.7. Karl Storz
  • 15.8. Ethicon
  • 15.9. Stryker
  • 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer